|Place of Origin:||CHINA|
|Minimum Order Quantity:||10g|
|Payment Terms:||L/C, T/T, Western Union, MoneyGram|
|Storage Temp.:||2-8°C||Solubility:||H2O: Soluble5mg/mL, Clear|
|Form:||Powder||Color:||White To Beige|
|Purity:||99%min||Grade Standard:||Phamaceutical Grade|
|Shelf Life:||2 Years When Properly Stored|
Ibutamoren mesylate (MK-677) is an active secretagogue.
Ibutamoren mesylate (MK-677) stimulates release through a pituitary and hypothalamic receptor that is different from the GHRH receptor. MK-677 is a item which acts as a potent, active gh secretagogue, mimicking the stimulating action of the endogenous ghrelin. It has been demonstrated to increase the release, and produces sustained increases in plasma levels, but without affecting cortisol levels. It is currently under development as a potential treatment for reduced levels, such as in deficient children or elderly adults, and human studies have shown it to increase both muscle mass and bone mineral density, making it a promising therapy for the treatment of frailty in the elderly. Ibutamoren mesylate (MK-0677) also alters metabolism of body fat and so may have application in the treatment of obesity.
An experimental meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. Exhibits selectivity for PPARd
Ibutamoren Mesylate Usage
An experimental item meant to control lipids and increase the level of HDL, or good cholesterol, in the
bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. Exhibits selectivity for
PPARd compared to PPARα and PPARγ. Does not exibit any activity against other nuclear or non-nuclear
receptors. Reported to increase cholesterol efflux and ABAC1 expression in macrophages, fibroblasts, and intestinal cells.
Ibutamoren Mesylate Benefits
the subjects showed a sustained increase in serum concentration;in addition, the nitrogen wasting was reversed, showing great potential for treatment of conditions involving muscle wasting.
A study done for the treatment of osteoporosis and bone mineral density showed some increase in bone density, so there is a true impact on bone mineral density. This can help with injury recovery during your cycle.
Hubei Vanz Pharm Co.,ltd. was founded in 2011 and We are comprehensive enterprise with business range covering R&D, production and sales of APIs, pharmaceutical intermediates, plant extracts, all kinds of organic intermediates and so on. We bought 14,000 square meters production base in Panhu Industrial Park, established several pharmaceutical synthesis production lines, and continually expands our production capacity.
We have a professional research team of highly qualified and experienced chemists. most of our R&D team are Master and higher. With their effort, we quickly transfer the science fruit into production. Our manufacturing site is located in Wuhan which is equipped with 100L~5000L reactors; we can offer one-stop services from R&D to commercial production. (Normal reaction/ High-pressure reaction/ Catalytic reaction/ Low-Temperature reaction).
Contact Person: Ms. Wendy Wang
Tel: +86 15927784577